Literature DB >> 3058821

A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil.

P G Kremsner1, G M Zotter, H Feldmeier, W Graninger, R M Rocha, G Wiedermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3058821     DOI： 10.1093/infdis/158.6.1368

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  19 in total

1.  Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics.

Authors:  P Parola; S Ranque; S Badiaga; M Niang; O Blin; J J Charbit; J Delmont; P Brouqui
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon.

Authors:  Mirjam Groger; Luzia Veletzky; Albert Lalremruata; Chiara Cattaneo; Johannes Mischlinger; Rella Zoleko-Manego; Lilian Endamne; Anna Klicpera; Johanna Kim; The Nguyen; Lena Flohr; Jonathan Remppis; Pierre-Blaise Matsiegui; Ayôla A Adegnika; Selidji T Agnandji; Peter G Kremsner; Benjamin Mordmüller; Ghyslain Mombo-Ngoma; Michael Ramharter
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

5.  Low interleukin-12 activity in severe Plasmodium falciparum malaria.

Authors:  A J Luty; D J Perkins; B Lell; R Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; K Herbich; D Schmid; J B Weinberg; P G Kremsner
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 6.  Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis.

Authors:  Charles O Obonyo; Elizabeth A Juma
Journal:  Malar J       Date:  2012-01-04       Impact factor: 2.979

7.  Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76.

Authors:  Khalid Beshir; Colin J Sutherland; Ioannis Merinopoulos; Naeem Durrani; Toby Leslie; Mark Rowland; Rachel L Hallett
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

8.  Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria.

Authors:  Estelle S Zang-Edou; Ulrick Bisvigou; Zacharie Taoufiq; Faustin Lékoulou; Jean Bernard Lékana-Douki; Yves Traoré; Dominique Mazier; Fousseyni S Touré-Ndouo
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

9.  High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic.

Authors:  W Metzger; B Mordmüller; W Graninger; U Bienzle; P G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.

Authors:  Geoffrey Ian McFadden; Christopher Dean Goodman; Taher Uddin
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.